Rationale and study design of the Italian Registry in the setting of Atrial Fibrillation Ablation with Rivaroxaban - IRIS.
Lavalle C, Magnocavallo M, Vetta G, Piro A, Borrelli A, Grimaldi M, Rossillo A, Notarstefano P, Carreras G, Addonisio L, Dello Russo A, Perna F, Castro A, Grossi S, Pandozi C, Pappalardo A, Sgarito G, Forleo GB.
Lavalle C, et al. Among authors: carreras g.
Minerva Cardiol Angiol. 2023 Feb;71(1):91-99. doi: 10.23736/S2724-5683.21.05832-4. Epub 2022 Jan 26.
Minerva Cardiol Angiol. 2023.
PMID: 35080355